Letter to the editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirus
暂无分享,去创建一个
M. Morfini | A. Azzi | G. Longo | P. Ferrini | M. Morfini | S. Ciappi | C. Zakrewska | P. Kolumban
[1] J. Abkowitz,et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. , 1990, Annals of internal medicine.
[2] K. Pasi,et al. Transmission of Human Parvovirus B19 by Coagulation Factor Concentrates , 1990, Vox sanguinis.
[3] N. Young,et al. Persistent parvovirus B19 infections in humans. , 1989, Microbial pathogenesis.
[4] M. Morfini,et al. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates , 1988, Journal of medical virology.
[5] N. Young,et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. , 1987, The New England journal of medicine.
[6] P. Mortimer,et al. TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATES , 1983, The Lancet.
[7] C. S. Jones. REGIONAL CURARISATION. ANAESTHESIA FOR SURGERY OF THE KNEE-JOINT. , 1963, Lancet.